All In Biotech

Drug Trial Radar · NCT02793583

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkin's Lymphoma

Last checked: Nov 20, 2026Latest source record: Jul 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 710 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

710

Actual

Start

May 25, 2016

Primary completion

May 31, 2022

Study completion Jul 4, 2022

Sponsor

Lead sponsor
TG Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jun 8, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

Conditions

  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Mantle Cell Lymphoma
  • Small Lymphocytic Lymphoma

Interventions

  • UblituximabBiological

  • UmbralisibDrug

  • BendamustineBiological

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response RateTime frame: Every 8-12 weeks, up to 2 years

Locations

168 sites in 9 countries. Site status is shown where the registry gives one.

  • TG Therapeutics Investigational Trial Site

    Birmingham, Alabama

  • TG Therapeutics Investigational Trial Site

    Huntsville, Alabama

  • TG Therapeutics Investigational Trial Site

    Chandler, Arizona

  • TG Therapeutics Investigational Trial Site

    Tucson, Arizona

  • TG Therapeutics Investigational Trial Site

    Tucson, Arizona

  • TG Therapeutics Investigational Trial Site

    Los Angeles, California

  • TG Therapeutics Investigational Trial Site

    Orange, California

  • TG Therapeutics Investigational Trial Site

    San Diego, California

  • TG Therapeutics Investigational Trial Site

    San Diego, California

  • TG Therapeutics Investigational Trial Site

    Whittier, California

  • TG Therapeutics Investigational Trial Site

    Aurora, Colorado

  • TG Therapeutics Investigational Trial Site

    Denver, Colorado

  • TG Therapeutics Investigational Trial Site

    Fort Collins, Colorado

  • TG Therapeutics Investigational Trial Site

    Bridgeport, Connecticut

  • TG Therapeutics Investigational Trial Site

    Newark, Delaware

  • TG Therapeutics Investigational Trial Site

    Washington D.C., District of Columbia

  • TG Therapeutics Investigational Trial Site

    Boca Raton, Florida

  • TG Therapeutics Investigational Trial Site

    Fort Myers, Florida

  • TG Therapeutics Investigational Trial Site

    Gainesville, Florida

  • TG Therapeutics Investigational Trial Site

    Jacksonville, Florida

  • TG Therapeutics Investigational Trial Site

    Jacksonville, Florida

  • TG Therapeutics Investigational Trial Site

    Jacksonville, Florida

  • TG Therapeutics Investigational Trial Site

    Miami, Florida

  • TG Therapeutics Investigational Trial Site

    St. Petersburg, Florida

  • TG Therapeutics Investigational Trial Site

    Tallahassee, Florida

  • TG Therapeutics Investigational Trial Site

    Tampa, Florida

  • TG Therapeutics Investigational Trial Site

    West Palm Beach, Florida

  • TG Therapeutics Investigational Trial Site

    Albany, Georgia

  • TG Therapeutics Investigational Trial Site

    Macon, Georgia

  • TG Therapeutics Investigational Trial Site

    Marietta, Georgia

  • TG Therapeutics Investigational Trial Site

    Chicago, Illinois

  • TG Therapeutics Investigational Trial Site

    Chicago, Illinois

  • TG Therapeutics Investigational Trial Site

    Decatur, Illinois

  • TG Therapeutics Investigational Trial Site

    Evanston, Illinois

  • TG Therapeutics Investigational Trial Site

    Harvey, Illinois

  • TG Therapeutics Investigational Trial Site

    Maywood, Illinois

  • TG Therapeutics Investigational Trial Site

    Niles, Illinois

  • TG Therapeutics Investigational Trial Site

    Peoria, Illinois

  • TG Therapeutics Investigational Trial Site

    Swansea, Illinois

  • TG Therapeutics Investigational Trial Site

    Fort Wayne, Indiana

Showing 40 of 168 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.